» Articles » PMID: 30818083

Targeting Cancer Stem Cells As Therapeutic Approach in the Treatment of Colorectal Cancer

Abstract

Colorectal cancer is one of the most common cancers globally. A large portion of colorectal cancer patients who are treated with conventional chemotherapy eventually develop local recurrence or metastases. The failure of a complete cure in colorectal cancer patients may be related to the lack of complete eradication of cancer stem cells when using conventional therapy. Colorectal cancer stem cells comprise a small population of tumor cells that possess the properties of rapid proliferation and differentiation. The colorectal cancer stem cells are also phenotypically and molecularly distinct, and resistant to conventional chemo-radiotherapy. Therefore, it is important to identify approaches in combination with conventional therapy for targeting and eradicating cancer cells. The aim of this review was to summarize the main findings of recent studies on targeting colorectal cancer stem cells as a novel therapeutic approach in colorectal cancer treatment.

Citing Articles

Melittin Inhibits Colorectal Cancer Growth and Metastasis by Ac-Tivating the Mitochondrial Apoptotic Pathway and Suppressing Epithelial-Mesenchymal Transition and Angiogenesis.

Wang K, Tao L, Zhu M, Yu X, Lu Y, Yuan B Int J Mol Sci. 2024; 25(21).

PMID: 39519238 PMC: 11546240. DOI: 10.3390/ijms252111686.


The Impact of Cancer Stem Cells in Colorectal Cancer.

Radu P, Zurzu M, Tigora A, Paic V, Bratucu M, Garofil D Int J Mol Sci. 2024; 25(8).

PMID: 38673727 PMC: 11050141. DOI: 10.3390/ijms25084140.


Colorectal Cancer Stem Cell Biomarkers: Biological Traits and Prognostic Insights.

Soleimani A, Saeedi N, Al-Asady A, Nazari E, Hanaie R, Khazaei M Curr Pharm Des. 2024; 30(18):1386-1397.

PMID: 38623972 DOI: 10.2174/0113816128291321240329050945.


Unraveling The Effects of DICER1 Overexpression on Immune-Related Genes Expression in Mesenchymal Stromal/Stem Cells: Insights for Therapeutic Applications.

Bidkhori H, Farshchian M, Hasanzadeh H, Esfehani R, Mahmoudian R, Moradi Marjaneh M Cell J. 2023; 25(10):696-705.

PMID: 37865878 PMC: 10591266. DOI: 10.22074/cellj.2023.1988987.1221.


Treatment with decitabine induces the expression of stemness markers, PD-L1 and NY-ESO-1 in colorectal cancer: potential for combined chemoimmunotherapy.

Taib N, Merhi M, Inchakalody V, Mestiri S, Hydrose S, Makni-Maalej K J Transl Med. 2023; 21(1):235.

PMID: 37004094 PMC: 10067322. DOI: 10.1186/s12967-023-04073-y.